延胡索酸酯治疗银屑病的作用机理及临床应用
Fumaric Acid Esters: Mechanisms and Clinical Use in the Treatment of Psoriasis
摘要
延胡索酸酯对银屑病发病机理中起重要作用的多种细胞具有调节作用。国外大量的临床研究证实,延胡索酸酯治疗银屑病效果好,副作用少,可以长期使用。本文就延胡索酸酯治疗银屑病的作用机理和临床应用进行综述。
出处
《中国皮肤性病学杂志》
CAS
北大核心
2005年第10期628-629,631,共3页
The Chinese Journal of Dermatovenereology
参考文献19
-
1Sebok B, Bonnekoh B, Vetter R, et al. The antipsoriatic dimethyl-fumarate suppress interferon-γ-induced ICAM-I and HLA-DR expression on hyperproliferative keratino-cytes. Quantification by culture plate-directed APAAP-ELISA technique [J]. Eur J Dermatol, 1998,8:29 - 32.
-
2Stoof TJ, Flier J, Sampat S, et al. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells[ J]. Br J Dermatol, 2001,144 : 1114 -1120.
-
3Vandermeeren M, Janssens S, Boergers M,et al. Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-I, and ICAM-I expression in human endothelial cells [ J ]. Biochem Biophys Res Commun,1997,234 : 19 - 23.
-
4Loewe R, Holnthoner W, Groger M, et al.Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells [ J ]. J Immunol, 2002, 168 :4781 - 4787.
-
5Zhu K, Mrowietz U. Inhibition of dendritic cell differentiation by fumaric acid esters[J]. J Invest Dermatol,2001,116:203 -208.
-
6Litjens NH, Rademaker M, Ravensbergen B,et al. Monomethylfumarate affects polariazation of monocyte-derived dendritic cells resulting in down-regulated Thl lymphocyte responses[J]. Eur J lmmunol,2004 ,34 :565-575.
-
7De Jong R, Bezemer AC, Zomerdijk TPL, et al. Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate [ J ]. Eur J Immunol,1996,26:2067 - 2074.
-
8Litjens NH, Nibbering PH, Barrois A J, et al.Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines[ J]. Br J Dermatol, 2003,148:444 - 451.
-
9Treumer F,Zhu K, Glaser R,et al. Dimethylfumarate is a potent inducer of apoptosis in human T cells[ J]. J Invest Dermatol,2003,121:1383 - 1388.
-
10Litjens NH,van Strijen E,van Gulpen C,et al. In vitro pharmacokinetics of anti-psoriatic fumaric acid esters [ J ]. BMC Pharmacol,2004,4:22.
-
1修海龙.延胡索酸酯治疗慢性湿疹的疗效观察[J].医药前沿,2016,0(5):56-58.
-
2Harries M.J.,Chalmers R.J.G.,Griffiths C.E.M.,刘艳.延胡索酸酯治疗重症银屑病的58例病例回顾[J].世界核心医学期刊文摘（皮肤病学分册）,2005,0(12):43-43.
-
3Kreuter A,Knierim C,Stücker M,罗素菊.延胡索酸酯类治疗类脂质渐进性坏死的前瞻性非对照研究[J].世界核心医学期刊文摘（皮肤病学分册）,2006,0(1):40-41.
-
4郑茂荣,聂本勇.第十届欧洲皮肤病及性病学术会议中关于银屑病的进展[J].中国皮肤性病学杂志,2003,17(3):205-206. 被引量：5
-
5朱可建,周伟芳,周凯,郑敏,Ulrich Mrowietz.延胡索酸酯对体外培养的树突状细胞分化的影响[J].浙江大学学报（医学版）,2002,31(6):453-456. 被引量：3
-
6楚瑞琦,王冬云,谭升顺,彭振辉.银屑病的系统给药治疗[J].中国皮肤性病学杂志,2003,17(5):347-349.
